Biweekly cetuximab and irinotecan as sec
โ
Katrine R. Schoennemann; Jon K. Bjerregaard; Tine P. Hansen; Karin De Stricker;
๐
Article
๐
2011
๐
Springer
๐
English
โ 200 KB